(Q50158174)

English

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

scientific article published on 30 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

multiple sclerosis

0 references

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Paul J Veugelers

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

J D Fisk

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M G Brown

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

K Stadnyk

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

T J Murray

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

V Bhan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

30 October 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1286-1294

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Interferons in relapsing remitting multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Disease-modifying therapy in multiple sclerosis: update and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Competing interests in multiple sclerosis research.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509350307

21 January 2018

Identifiers

10.1177/1352458509350307

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19965558%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50158174&oldid=1114465628"